Replies to post #4989351 on BB's Stock Haven

[Edward]

Correction:

Since 12/24/2024 CTOR IS UP 38.3% AND UP 13% IN THE FIRST 2 TRADING DAYS OF 2025.

Original post stated 30.3% which is incorrect.

Newly approved cancer treatment by the FDA set for initial sales in the 1st QUARTER OF 2025.

This is CTOR's first and only product currently.

CTOR has a small float of appox. 5.9 million shares ( see (A) below:

The market cap is appox. $93 million.

( A) CTOR has 71,552,402 shares O/S a/o 9/30/2024, whereas CTXR owns 92.2%.